- Published on
Medicine – Pancytopenia
Pancytopenia is a haematological condition characterised by a reduction in all three major peripheral blood cell lines:
- Red blood cells: Anaemia.
- White blood cells: Leukopenia, often with neutropenia.
- Platelets: Thrombocytopenia.
Pancytopenia is not a disease itself but a manifestation of an underlying disorder affecting blood cell production, survival or distribution.
The major causes of pancytopenia include aplastic anaemia, megaloblastic anaemia, bone marrow failure or infiltration, and hypersplenism.
1. Pathophysiology
Pancytopenia develops through three principal mechanisms:
- Reduced bone marrow production: Failure or ineffective production of blood cells.
- Bone marrow infiltration or replacement: Disruption of normal haematopoiesis by malignant cells or fibrosis.
- Peripheral sequestration or destruction: Increased removal of blood cells from the circulation, particularly in hypersplenism.
Pathophysiology Flowchart
2. Causes of Pancytopenia
A. Aplastic Anaemia
Aplastic anaemia is a bone marrow failure syndrome characterised by markedly reduced haematopoietic stem cells and a hypocellular bone marrow.
Causes
- Idiopathic or immune-mediated aplastic anaemia.
- Cytotoxic chemotherapy.
- Radiotherapy.
- Certain medications, including chloramphenicol and some antithyroid drugs.
- Viral infections, including hepatitis-associated aplastic anaemia.
- Inherited marrow failure syndromes, such as Fanconi anaemia.
Characteristic Findings
- Pancytopenia.
- Low reticulocyte count.
- Hypocellular bone marrow.
- Usually no splenomegaly in uncomplicated aplastic anaemia.
B. Megaloblastic Anaemia
Megaloblastic anaemia results from impaired DNA synthesis, most commonly due to vitamin B12 or folate deficiency.
Severe deficiency may produce pancytopenia because all three blood cell lines are affected.
Characteristic Findings
- Macrocytosis.
- Macro-ovalocytes.
- Hypersegmented neutrophils.
- Low reticulocyte count before treatment.
- Hypercellular bone marrow with ineffective haematopoiesis.
C. Bone Marrow Disorders and Infiltration
Diseases that replace or disrupt normal bone marrow can suppress the production of all three blood cell lines.
| Cause | Mechanism |
|---|---|
| Leukaemia | Accumulation of malignant cells suppresses normal haematopoiesis. |
| Myelodysplastic neoplasms (MDS) | Ineffective and dysplastic blood cell production. |
| Myelofibrosis | Marrow fibrosis disrupts normal haematopoiesis. |
| Multiple myeloma | Plasma cell infiltration may suppress marrow function. |
| Metastatic carcinoma | Malignant infiltration replaces normal marrow. |
| Lymphoma | Bone marrow infiltration may produce cytopenias. |
Leukaemia
Acute leukaemias, including AML and ALL, commonly produce pancytopenia through marrow replacement.
The peripheral blood film may show circulating blasts, although blasts are not always present.
Myelodysplastic Neoplasms
MDS involves clonal abnormalities of haematopoietic stem cells, resulting in ineffective blood cell production.
It is more common in older adults and may progress to acute myeloid leukaemia.
Myelofibrosis
Myelofibrosis may cause pancytopenia, particularly in advanced disease.
Typical blood film findings include:
- Tear-drop cells (dacrocytes).
- Nucleated red blood cells.
- Immature granulocytes.
- Leucoerythroblastic blood picture.
Multiple Myeloma, Carcinoma and Lymphoma
These malignancies may infiltrate the marrow and impair normal blood cell production.
Metastatic marrow infiltration may also produce a leucoerythroblastic blood picture.
D. Hypersplenism
Hypersplenism refers to increased sequestration and destruction of circulating blood cells by an enlarged or overactive spleen.
Common Causes
- Liver cirrhosis with portal hypertension.
- Chronic liver disease.
- Haematological malignancies.
- Certain infections.
- Infiltrative splenic disorders.
Characteristic Features
- Splenomegaly, although spleen size varies.
- Thrombocytopenia, often the earliest or most prominent cytopenia.
- Anaemia and leukopenia in more pronounced cases.
- Bone marrow production may be preserved or increased.
3. Other Important Causes
Additional causes of pancytopenia include:
- Severe infections, including HIV, tuberculosis and some viral infections.
- Sepsis.
- Haemophagocytic lymphohistiocytosis (HLH).
- Autoimmune disorders, particularly systemic lupus erythematosus.
- Copper deficiency.
- Drugs causing marrow suppression or immune-mediated cytopenias.
- Paroxysmal nocturnal haemoglobinuria (PNH), particularly when associated with marrow failure.
4. Clinical Features
Clinical manifestations arise from the reduction in each blood cell line.
| Deficient Cell Line | Clinical Manifestations |
|---|---|
| Red blood cells | Pallor, fatigue, dyspnoea, dizziness, palpitations. |
| Neutrophils | Fever, recurrent infections, sepsis. |
| Platelets | Petechiae, purpura, bruising, epistaxis, gum bleeding. |
Additional Clinical Findings
- Splenomegaly: Hypersplenism, myelofibrosis or haematological malignancy.
- Lymphadenopathy: Leukaemia, lymphoma or infection.
- Bone pain: Marrow infiltration or malignancy.
- Neurological abnormalities: Vitamin B12 deficiency.
- Weight loss and night sweats: Possible malignancy or chronic infection.
5. Investigations
A. Full Blood Count
The full blood count confirms reduction in all three major blood cell lines.
The severity and pattern of cytopenias help guide further assessment.
B. Peripheral Blood Film
| Blood Film Finding | Possible Diagnosis |
|---|---|
| Macro-ovalocytes and hypersegmented neutrophils | Megaloblastic anaemia |
| Circulating blasts | Acute leukaemia |
| Tear-drop cells | Myelofibrosis or marrow infiltration |
| Leucoerythroblastic picture | Marrow infiltration or fibrosis |
| Dysplastic neutrophils or other cells | Myelodysplastic neoplasm |
| Relatively unremarkable RBC morphology with cytopenias | May occur in aplastic anaemia |
C. Reticulocyte Count
The reticulocyte count helps assess bone marrow red cell production.
- Low reticulocyte count: Suggests impaired red cell production.
- Raised reticulocyte count: May indicate haemolysis or blood loss, although interpretation depends on the severity of anaemia.
D. Additional Blood Investigations
- Vitamin B12 and folate.
- Liver and renal function tests.
- LDH, bilirubin and haptoglobin.
- Viral testing when indicated.
- Autoimmune investigations when appropriate.
- Copper studies in selected cases.
E. Bone Marrow Examination
Bone marrow aspiration and trephine biopsy may be required when the cause remains unclear or marrow disease is suspected.
| Bone Marrow Finding | Possible Diagnosis |
|---|---|
| Hypocellular marrow | Aplastic anaemia |
| Megaloblastic erythropoiesis | Vitamin B12 or folate deficiency |
| Increased blasts | Acute leukaemia |
| Dysplasia | Myelodysplastic neoplasm |
| Fibrosis | Myelofibrosis |
| Malignant cell infiltration | Myeloma, lymphoma or metastatic carcinoma |
6. Diagnostic Approach
7. Management
Management depends on the underlying cause of pancytopenia.
| Cause | General Treatment Approach |
|---|---|
| Aplastic anaemia | Immunosuppressive therapy or stem cell transplantation in selected patients |
| Megaloblastic anaemia | Vitamin B12 or folate replacement as appropriate |
| Leukaemia | Disease-specific chemotherapy, targeted therapy or transplantation |
| Myelodysplastic neoplasm | Supportive care and risk-adapted treatment |
| Myelofibrosis | Disease-specific therapy and supportive care |
| Marrow infiltration | Treatment of the underlying malignancy |
| Hypersplenism | Management of the underlying cause |
Supportive Care
- Red blood cell transfusions when clinically indicated.
- Platelet transfusions when indicated.
- Prompt assessment and treatment of infection.
- Review and withdrawal of causative drugs when appropriate.
- Monitoring of blood counts and complications.
When vitamin B12 deficiency is possible, it should be assessed and treated appropriately; folate alone may correct anaemia while neurological injury from B12 deficiency continues.
8. High-Yield Examination Summary
| Feature | Key Point |
|---|---|
| Definition | Reduction in RBCs, WBCs and platelets |
| Aplastic anaemia | Hypocellular marrow |
| Megaloblastic anaemia | Macro-ovalocytes and hypersegmented neutrophils |
| Leukaemia | Marrow infiltration by blasts |
| Myelodysplasia | Ineffective, dysplastic haematopoiesis |
| Myelofibrosis | Tear-drop cells and marrow fibrosis |
| Myeloma | Plasma cell infiltration |
| Carcinoma / lymphoma | Malignant marrow infiltration |
| Hypersplenism | Splenic sequestration of blood cells |
| Key initial investigations | FBC, blood film and reticulocyte count |
| Bone marrow investigation | Aspiration and trephine biopsy when indicated |
9. Key Examination Pearls
- Pancytopenia is a finding, not a final diagnosis.
- Aplastic anaemia causes pancytopenia with a hypocellular bone marrow.
- Severe vitamin B12 or folate deficiency can cause pancytopenia.
- Acute leukaemia may present with pancytopenia even without a high white cell count.
- Tear-drop cells suggest myelofibrosis or marrow infiltration.
- A leucoerythroblastic blood picture suggests disruption of normal marrow architecture.
- Hypersplenism causes sequestration of blood cells, often with prominent thrombocytopenia.
- The reticulocyte count helps assess marrow red cell production.
- Bone marrow examination is important when a primary marrow disorder is suspected.
Pancytopenia with a hypocellular marrow suggests aplastic anaemia; pancytopenia with macro-ovalocytes and hypersegmented neutrophils suggests megaloblastic anaemia; and pancytopenia with tear-drop cells and a leucoerythroblastic blood picture suggests marrow fibrosis or infiltration.
Pancytopenia accompanied by fever, severe neutropenia, active bleeding or haemodynamic instability requires urgent medical assessment.
Kembara Xtra – Medicine Revision Notes